• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因 Pro512Ala 多态性与非酒精性脂肪性肝病的关联。

Association of gene Pro512Ala polymorphism with nonalcoholic fatty liver disease.

机构信息

University of Mohaghegh Ardabili Faculty of Science Department of Biology Ardabil Iran Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.

Shahid Beheshti University of Medical Sciences Research Institute for Gastroenterology and Liver Diseases Gastroenterology and Liver Diseases Research Center Tehran Iran Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Arch Endocrinol Metab. 2024 Aug 26;68:e230216. doi: 10.20945/2359-4292-2023-0216. eCollection 2024.

DOI:10.20945/2359-4292-2023-0216
PMID:39420901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11460970/
Abstract

OBJECTIVE

This study was designed to investigate the possible effect of the insulin receptor substrate 1 gene rs1801276 polymorphism on the risk of nonalcoholic fatty liver disease (NAFLD).

SUBJECTS AND METHODS

The rs1801276 polymorphism was investigated in 127 controls and 123 biopsy-proven NAFLD patients using PCR-RFLP.

RESULTS

No deviation from Hardy-Weinberg equilibrium was discovered for the rs1801276 variant of in either NAFLD patients or controls (>0.05). The distribution of different rs1801276 genotypes and alleles showed significant variations between controls and NAFLD patients. In comparison to rs1801276 'CC' genotype, the "GG+GC" genotype occurred less frequently in NAFLD patients than in controls, which also persisted after adjustment for confounding factors ( = 0.041, OR = 0.60, 95% CI = 0.45-0.93). In comparison with the rs1801276 "C" allele, the "G" allele was significantly less prevalent in NAFLD patients than in controls ( = 0.045, OR = 0.69, 95% CI = 0.58-0.91).

CONCLUSIONS

For the first time, we reported a significant association between the rs1801276 polymorphism and biopsy-proven NAFLD. More studies are required to further elucidate the contribution of the gene to NAFLD susceptibility.

摘要

目的

本研究旨在探讨胰岛素受体底物 1 基因 rs1801276 多态性对非酒精性脂肪性肝病(NAFLD)风险的可能影响。

对象和方法

采用 PCR-RFLP 法对 127 例对照和 123 例经肝活检证实的 NAFLD 患者进行 rs1801276 多态性检测。

结果

在 NAFLD 患者和对照组中,rs1801276 变体均未偏离 Hardy-Weinberg 平衡(>0.05)。不同 rs1801276 基因型和等位基因的分布在对照组和 NAFLD 患者之间存在显著差异。与 rs1801276“CC”基因型相比,“GG+GC”基因型在 NAFLD 患者中比在对照组中发生的频率较低,在调整混杂因素后仍然如此(=0.041,OR=0.60,95%CI=0.45-0.93)。与 rs1801276“C”等位基因相比,“G”等位基因在 NAFLD 患者中明显较对照组少见(=0.045,OR=0.69,95%CI=0.58-0.91)。

结论

我们首次报道了 rs1801276 多态性与经肝活检证实的 NAFLD 之间存在显著关联。需要进一步的研究来阐明 基因对 NAFLD 易感性的贡献。

相似文献

1
Association of gene Pro512Ala polymorphism with nonalcoholic fatty liver disease.基因 Pro512Ala 多态性与非酒精性脂肪性肝病的关联。
Arch Endocrinol Metab. 2024 Aug 26;68:e230216. doi: 10.20945/2359-4292-2023-0216. eCollection 2024.
2
Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians.IRS1(Gly972Arg)和 IRS2(Gly1057Asp)基因多态性与亚洲印第安人 OSA 和 NAFLD 的关系。
PLoS One. 2021 Aug 27;16(8):e0245408. doi: 10.1371/journal.pone.0245408. eCollection 2021.
3
Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.胰岛素受体底物2基因Gly1057Asp多态性是非酒精性脂肪性肝病的一个危险因素。
Lab Med. 2024 Mar 7;55(2):215-219. doi: 10.1093/labmed/lmad066.
4
The rs1862513 promoter variant of resistin gene influences susceptibility to nonalcoholic fatty liver disease.抵抗素基因的rs1862513启动子变异影响非酒精性脂肪性肝病的易感性。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20231537. doi: 10.1590/1806-9282.20231537. eCollection 2024.
5
NAMPT gene rs2058539 variant is a risk factor for nonalcoholic fatty liver disease.NAMPT 基因 rs2058539 变体是非酒精性脂肪性肝病的危险因素。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(7):e20230188. doi: 10.1590/1806-9282.20230188. eCollection 2024.
6
A 3'-untranslated region variant (rs2289046) of insulin receptor substrate 2 gene is associated with susceptibility to nonalcoholic fatty liver disease.胰岛素受体底物2基因的一个3'非翻译区变异(rs2289046)与非酒精性脂肪性肝病易感性相关。
Acta Gastroenterol Belg. 2020 Apr-Jun;83(2):271-276.
7
Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study.IGF1 基因启动子区 rs5742612 多态性与非酒精性脂肪性肝病的相关性:一项病例对照研究。
Lab Med. 2022 Sep 1;53(5):504-508. doi: 10.1093/labmed/lmac039.
8
Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.脂联素基因多态性与台湾2型糖尿病患者非酒精性脂肪性肝病的相关性
PLoS One. 2015 Jun 4;10(6):e0127521. doi: 10.1371/journal.pone.0127521. eCollection 2015.
9
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.载脂蛋白基因多态性与儿童非酒精性脂肪性肝病的关系: 荟萃分析。
BMC Med Genet. 2020 Aug 18;21(1):163. doi: 10.1186/s12881-020-01098-8.
10
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.PNPLA3基因rs738409多态性与非酒精性脂肪性肝病(NAFLD)易感性及严重程度的关联:一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324.

本文引用的文献

1
Insulin-like growth factor binding protein 3 promoter variant (rs2854744) is associated with nonalcoholic fatty liver disease.胰岛素样生长因子结合蛋白 3 启动子变异(rs2854744)与非酒精性脂肪性肝病有关。
Arch Endocrinol Metab. 2023 Nov 10;68:e230017. doi: 10.20945/2359-4292-2023-0017.
2
A visfatin gene promoter polymorphism (rs1319501) is associated with susceptibility to nonalcoholic fatty liver disease.黏附素基因启动子多态性(rs1319501)与非酒精性脂肪性肝病易感性相关。
Per Med. 2023 Mar;20(2):157-165. doi: 10.2217/pme-2022-0100. Epub 2023 May 18.
3
The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.非酒精性脂肪性肝病与2型糖尿病的共存
J Clin Med. 2022 Mar 2;11(5):1375. doi: 10.3390/jcm11051375.
4
Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population.肝脏脂肪变性指数与筛查人群中通过非增强CT诊断的非酒精性脂肪性肝病的关联
Diagnostics (Basel). 2021 Nov 23;11(12):2168. doi: 10.3390/diagnostics11122168.
5
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程:共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.
6
The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease.胃饥饿素基因中rs26802变异体的“GG”基因型是预防非酒精性脂肪性肝病的潜在保护因素。
Physiol Int. 2021 Sep 16;108(3):342-352. doi: 10.1556/2060.2021.00183.
7
Obesity, insulin resistance and their interaction on liver enzymes.肥胖、胰岛素抵抗及其对肝酶的相互作用。
PLoS One. 2021 Apr 21;16(4):e0249299. doi: 10.1371/journal.pone.0249299. eCollection 2021.
8
INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE.胰岛素及胰岛素受体基因多态性与非酒精性脂肪性肝病易感性
Arq Gastroenterol. 2020 Apr-Jun;57(2):203-208. doi: 10.1590/S0004-2803.202000000-39.
9
A Missense Mutation in IRS1 is Associated with the Development of Early-Onset Type 2 Diabetes.胰岛素受体底物1中的错义突变与早发型2型糖尿病的发生有关。
Int J Endocrinol. 2020 Jan 25;2020:9569126. doi: 10.1155/2020/9569126. eCollection 2020.
10
Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.芡实种皮提取物通过增加IRS-1和抑制CYP2E1对高脂饮食诱导的小鼠非酒精性脂肪性肝病的肝保护作用。
J Oleo Sci. 2019 Jun 6;68(6):581-589. doi: 10.5650/jos.ess19018. Epub 2019 May 16.